Answers are grounded in this paper and cite their sources.
. (COVID-19) - , SARS-CoV-2. - . c (LVAD) , - . COVID-19 LVAD . . LVAD- , OVID-19 2020 . 2021 .: , , . . 177 LVAD, . 41 (23,2%) COVID-19. 55 ( 17-75), 9 (21,9%) -. (n=36, 87,8%) LVAD HeartMate 3. -19 (46%) - (). LVAD- 1 83 COVID-19. 13 (31,7%) ( 94%) . 3 (1,7% 177 , LVAD-, 7,3% COVID-19) . . LVAD- COVID-19 . , - , COVID-19 LVAD-. , , , , , , LVAD- COVID-19.
No takes yet. Share an insight, caveat, or question.
Bekbossynova et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: